Jump to content

NSCLC Spouso


Chris2YEA

Recommended Posts

My wife has been diagnosed with NSCLC Andeocarcinoma Stage 4 advanced. Left lung, both lobes of the liver, back, ribs, and hip. Started on radiation and Tagrisso. New to this, was wondering if anyone had more info on the success of Tagrisso. 

Link to comment
Share on other sites

Hello Chris2YEA. I just wanted to say welcome. I'm sorry about your wife's diagnosis. I think there are forum members who have experience with Tagrisso and hope that they will respond. If you don't get a response within a day or so of this post, I suggest you post in the EFGR subgroup under NSCLC, naming the topic Tagrisso. I think there's a facebook group for people with EFGR - maybe someone on the EFCR subgroup here can tell you about that? 

Bridget O

Link to comment
Share on other sites

  • 2 weeks later...

Hi, Chris,

Welcome to LCSC. I'm glad you've already connected with a few members. There are definitely people on this site who have experience with Tagrisso. I will reach out and encourage them to respond in this thread. You may also want to explore the EGFR forum in this site: https://forums.lungevity.org/forum/54-egfr/

If you are on Facebook, here is a link to the EGFR group that BridgetO mentioned: https://www.facebook.com/groups/EGFRlung/

We are here for you! Please feel free to ask questions, share updates, and join the conversations that resonate with you.

With gratitude,

Lauren
--
Digital Community Manager
LUNGevity Foundation

 

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.